CNM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Buy CNM now: price ($55.91) is near pivot support ($55.99) with limited downside to S1 ($53.32) and multiple bullish fundamental/Street signals.", "Upside setup looks better than downside: most recent Wall Street targets cluster above the current price (roughly $57\u2013$65), implying room for near-term upside even without a perfect technical entry.", "Options positioning is strongly risk-on (very low put/call ratios), which supports buying now for an impatient investor."]
["Trend/Momentum: MACD histogram is negative (-0.493) but negatively contracting, suggesting downside momentum is fading rather than accelerating.", "RSI(6)=47.43 (neutral): no overbought/oversold edge; favors taking cues from support/resistance rather than momentum chasing.", "Moving averages are converging: consistent with a consolidation phase and a potential breakout attempt rather than a strong trend.", "Key levels: Pivot ~55.99 (price is essentially at pivot). Support S1 ~53.32 then S2 ~51.67. Resistance R1 ~58.66 then R2 ~60.31. A move through ~$58.66 would improve the technical picture materially.", "Pattern-based short-horizon stats imply mild drift lower (-1.05% next week; -1.34% next month), but this is not a strong bearish call given the current neutral indicators."]
["Hedge fund accumulation: buying amount increased 339.34% over the last quarter (institutional demand tailwind).", "Latest quarter showed continued growth and margin improvement (supports higher earnings power).", "Analyst targets have generally been revised upward recently (Street confidence improving)."]
["Macro sensitivity: commentary highlights housing affordability, rates, tariffs/policy changes as risks for the broader group.", "Short-term technicals are not yet in a clean uptrend (MACD still below zero; moving averages not decisively bullish).", "No fresh news catalyst in the last week to force an immediate repricing higher."]
["Latest reported quarter: 2026/Q3.", "Revenue: $2.062B, +1.18% YoY (steady, modest top-line growth).", "Net income: $137M, +3.01% YoY (profit growing faster than revenue).", "EPS: $0.72, +4.35% YoY (shareholder earnings improving).", "Gross margin: 24.98, +2.42% YoY (margin expansion trend is a key positive)."]
["Recent trend: multiple firms raised price targets from Dec 2025 to Jan 2026 (generally constructive revisions).", "Highlights: RBC raised PT to $63 (Outperform); Deutsche Bank to $65 (Buy); Baird to $64 (Outperform); JPMorgan to $59 (Overweight); Wells Fargo to $57 (Overweight); Citi to $60 (Neutral, but PT raised).", "Wall Street pros: distribution model favored within the group; improving municipal demand and margin initiatives cited; post-Q3 results made the stock 'easier to own'.", "Wall Street cons: cautious tone into early 2026 due to housing affordability, mixed nonresidential demand, and rate/policy/tariff uncertainty.", "Influential/political flows: no recent congress trading data available; insiders reported as neutral with no significant recent trend."]
